Related Experiment Videos

Intraerythrocyte nonprotein-bound iron and plasma malondialdehyde in the hypoxic newborn

G Buonocore1, S Zani, S Perrone

  • 1Istituto di Pediatria Preventiva e Neonatologia, Università di Siena, Italia. buonocore@unisi.it

Insights

Newborns experiencing hypoxia show increased oxidative stress markers like malondialdehyde (MDA). Preterm infants and those requiring intubation had higher MDA levels, indicating red blood cells and lipoproteins are targets of this stress.

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Pediatric Research

Background:

  • Oxidative stress is a significant concern in newborns, particularly those born preterm or experiencing hypoxic events.
  • Malondialdehyde (MDA) is a key biomarker for lipid peroxidation and oxidative damage.

Purpose of the Study:

  • To investigate the levels of intraerythrocyte nonprotein-bound iron (INPBI), malondialdehyde (MDA), and hypoxanthine plasma levels (HxPL) in newborns.
  • To identify factors associated with elevated MDA levels in neonatal blood samples.

Main Methods:

  • High-pressure liquid chromatography was used to quantify INPBI, MDA, and HxPL in 138 newborns.
  • Blood samples were collected at birth (cord blood) and on the fourth day of life.
  • Statistical analyses, including correlation and multiple regression, were performed.

Main Results:

  • MDA plasma levels were significantly higher in preterm infants, those born via emergency Cesarean section, and intubated newborns.
  • Significant correlations were found between MDA levels and gestational age, birth weight, Apgar scores, HxPL, pH, base deficit, and INPBI.
  • Hypoxanthine plasma levels predicted MDA in cord blood, while INPBI predicted MDA in fourth-day blood.

Conclusions:

  • Hypoxia-induced oxidative stress affects neonatal red blood cells and plasma lipoproteins.
  • MDA levels serve as a sensitive indicator of oxidative stress in newborns, influenced by various clinical factors.

Related Concept Videos